Tehran University of Medical Sciences

Science Communicator Platform

Share By
The Application of Direct Viral Cytopathic Hypothesis to Design Drug Trials in the Battle Against Covid-19 Publisher Pubmed



Ashraf MA1 ; Sherafat A2 ; Pourdast A3, 4 ; Nazemi P4 ; Mohraz M3
Authors

Source: DARU# Journal of Pharmaceutical Sciences Published:2020


Abstract

COVID-19 has caused many deaths worldwide. Systemic complications alongside coagulopathy, and ARDS account for the majority of COVID-19 mortalities. The pathogenesis of the disease can be explained by two theories of direct viral cytopathy and systemic inflammatory cascade of events. ACE-2 is shown to be the cellular host receptor for SARS-CoV-2. It might be the key to explain the pathogenesis of systemic complications with a focus on the direct viral cytopathic hypothesis. Different medications tend to show up in many in vitro drug screens. However, more trials are needed to translate their application into in vivo efficacy. © 2020, Springer Nature Switzerland AG.
Related Docs
View other Related Docs
1. The Possible Double-Edged Sword Effects of Vitamin D on Covid-19: A Hypothesis, Cell Biology International (2021)
2. Sars-Cov-2: From the Pathogenesis to Potential Anti-Viral Treatments, Biomedicine and Pharmacotherapy (2021)
3. Potential Role of Interferons in Treating Covid-19 Patients, International Immunopharmacology (2021)
Experts (# of related papers)
View all Related Experts
Nima Rezaei (5)
Farshid Noorbakhsh (1)
Other Related Docs
4. An Overview of the Recent Findings of Cell-Based Therapies for the Treatment and Management of Covid-19, International Immunopharmacology (2021)
5. Pathological Effects of Sars-Cov-2 on Hematological and Immunological Cells: Alterations in Count, Morphology, and Function, Pathology Research and Practice (2022)
6. Severe Acute Respiratory Syndrome and Thyroid: A Molecular Point of View, Clinical Nutrition ESPEN (2022)
7. Molecular Mechanisms and Therapeutic Effects of Different Vitamins and Minerals in Covid-19 Patients, Journal of Trace Elements in Medicine and Biology (2022)
8. Immunology, Immunopathogenesis and Immunotherapeutics of Covid-19; an Overview, International Immunopharmacology (2021)
9. Geriatrics and Covid-19, Advances in Experimental Medicine and Biology (2021)
10. Statins: Beneficial Effects in Treatment of Covid-19, Advances in Experimental Medicine and Biology (2023)
11. Therapeutic Strategies for Covid-19 Patients: An Update, Infectious Disorders - Drug Targets (2022)
12. Gastrointestinal, Liver, Pancreas, Oral and Psychological Long-Term Symptoms of Covid-19 After Recovery: A Review, Mini-Reviews in Medicinal Chemistry (2023)
13. Structure-Based Study of Immune Receptors As Eligible Binding Targets of Coronavirus Sars-Cov-2 Spike Protein, Journal of Molecular Graphics and Modelling (2021)
14. Potential Therapeutic Options for Covid-19: An Update on Current Evidence, European Journal of Medical Research (2022)
15. Therapeutic Status of Famotidine in Covid-19 Patients: A Review, Infectious Disorders - Drug Targets (2022)
16. Overview of the Current Promising Approaches for the Development of an Effective Severe Acute Respiratory Syndrome Coronavirus 2 (Sars-Cov-2) Vaccine, International Immunopharmacology (2020)
17. Pharmacotherapy Consideration of Thrombolytic Medications in Covid-19-Associated Ards, Journal of Intensive Care (2022)
18. How Covid-19 Has Globalized: Unknown Origin, Rapid Transmission, and the Immune System Nourishment, Advances in Experimental Medicine and Biology (2021)
19. The Under-Reported Role of Toxic Substance Exposures in the Covid-19 Pandemic, Food and Chemical Toxicology (2020)
20. Computational Drug Discovery and Repurposing for the Treatment of Covid-19: A Systematic Review, Bioorganic Chemistry (2021)